Geode Capital Management, LLC Lixte Biotechnology Holdings, Inc. Transaction History

Geode Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.51 - $1.89 $38,461 - $142,534	75,415 Added 292.37%	101,209 $84,000
Q2 2022 Aug 12, 2022	SELL	$0.12 - $0.35 $1,821 - $5,312	-15,179 Reduced 37.05%	25,794 $19,000
Q1 2022 May 13, 2022	BUY	$0.16 - $0.35 $50 - $110	315 Added 0.77%	40,973 $49,000
Q4 2021 Feb 11, 2022	BUY	$0.21 - $0.57 $659 - $1,790	3,142 Added 8.38%	40,658 $48,000
Q3 2021 Nov 12, 2021	BUY	$0.52 - $0.85 $19,508 - $31,888	37,516 New	37,516 $78,000

Ticker LIXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,646,600
Market Cap $33M
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.